» Articles » PMID: 20018107

SUPPORT Tools for Evidence-informed Health Policymaking (STP) 17: Dealing with Insufficient Research Evidence

Overview
Publisher Biomed Central
Date 2009 Dec 19
PMID 20018107
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

This article is part of a series written for people responsible for making decisions about health policies and programmes and for those who support these decision makers. In this article, we address the issue of decision making in situations in which there is insufficient evidence at hand. Policymakers often have insufficient evidence to know with certainty what the impacts of a health policy or programme option will be, but they must still make decisions. We suggest four questions that can be considered when there may be insufficient evidence to be confident about the impacts of implementing an option. These are: 1. Is there a systematic review of the impacts of the option? 2. Has inconclusive evidence been misinterpreted as evidence of no effect? 3. Is it possible to be confident about a decision despite a lack of evidence? 4. Is the option potentially harmful, ineffective or not worth the cost?

Citing Articles

Supporting the use of research evidence in decision-making in crisis zones in low- and middle-income countries: a critical interpretive synthesis.

Khalid A, Lavis J, El-Jardali F, Vanstone M Health Res Policy Syst. 2020; 18(1):21.

PMID: 32070370 PMC: 7027202. DOI: 10.1186/s12961-020-0530-2.


The governmental health policy-development process for Syrian refugees: an embedded qualitative case studies in Lebanon and Ontario.

Khalid A, Lavis J, El-Jardali F, Vanstone M Confl Health. 2019; 13:48.

PMID: 31649748 PMC: 6805559. DOI: 10.1186/s13031-019-0231-z.


The GRADE Evidence to Decision (EtD) framework for health system and public health decisions.

Moberg J, Oxman A, Rosenbaum S, Schunemann H, Guyatt G, Flottorp S Health Res Policy Syst. 2018; 16(1):45.

PMID: 29843743 PMC: 5975536. DOI: 10.1186/s12961-018-0320-2.


A Qualitative Assessment of the Evidence Utilization for Health Policy-Making on the Basis of SUPPORT Tools in a Developing Country.

Imani-Nasab M, Seyedin H, Yazdizadeh B, Majdzadeh R Int J Health Policy Manag. 2017; 6(8):457-465.

PMID: 28812845 PMC: 5553214. DOI: 10.15171/ijhpm.2016.158.


Tobacco Use during Pregnancy and Its Associated Factors in a Mountain District of Eastern Nepal: A Cross-Sectional Questionnaire Survey.

Barakoti R, Ghimire A, Pandey A, Baral D, Pokharel P Front Public Health. 2017; 5:129.

PMID: 28634580 PMC: 5459881. DOI: 10.3389/fpubh.2017.00129.


References
1.
Alderson P, Roberts I . Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev. 2005; (1):CD000196. PMC: 7043302. DOI: 10.1002/14651858.CD000196.pub2. View

2.
Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman A, Sturm H . Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database Syst Rev. 2008; (1):CD007017. DOI: 10.1002/14651858.CD007017. View

3.
Lavis J, Oxman A, Lewin S, Fretheim A . SUPPORT Tools for evidence-informed health Policymaking (STP). Health Res Policy Syst. 2009; 7 Suppl 1:I1. PMC: 3271819. DOI: 10.1186/1478-4505-7-S1-I1. View

4.
Guyatt G, DiCenso A, Farewell V, Willan A, Griffith L . Randomized trials versus observational studies in adolescent pregnancy prevention. J Clin Epidemiol. 2000; 53(2):167-74. DOI: 10.1016/s0895-4356(99)00160-2. View

5.
. Surgeon General's advisory on the use of salicylates and Reye syndrome. MMWR Morb Mortal Wkly Rep. 1982; 31(22):289-90. View